Source: PhRMA, “Rare Diseases and the Orphan Drug Act.” 2019. Available at: https://onphr.ma/2TpdarX





What is the current situation for rare diseases and orphan drug development?
Source: PhRMA, “Rare Diseases and the Orphan Drug Act.” 2019. Available at: https://onphr.ma/2TpdarX
Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.
After finishing my degree, I envisioned a career in science communications. However, life took an unexpected turn and I ended up teaching abroad. Though the experience was amazing and I learned a great deal from it, I jumped at the opportunity to work for Texere. I'm excited to see where this new journey takes me!
False
False
February 3, 2025
4 min read
With new cases of avian influenza appearing, what does this mean for global health and what are drug developers doing about it?
December 1, 2014
0 min read
Can phage endolysins revolutionize the way bacterial infections are treated – and prevent drug resistance?
April 2, 2025
2 min read
How fluid flow through the body can affect the ways in which antibiotics work.
April 7, 2025
4 min read
Celon Pharma CEO hopes their new compound could be a potential breakthrough for Parkinson’s patients.